Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

IPAB: A Backstop To Control Medicare Costs, Or A Power Shift To The Executive Branch?

This article was originally published in The Gray Sheet

Executive Summary

What the health-care-reform-created Independent Payment Advisory Board can and cannot do is clearly in the eyes of the beholder.
Advertisement

Related Content

HHS Appointee Burwell Tells Senate Panel IPAB Will ‘Never Be Activated’
House Committees Set Key Subpanel Assignments For 113th Congress
IPAB Repeal Bill Clears House Subcommittee
Reimbursement In Brief
Reimbursement In Brief
Industry Worries New Medicare Board Will Be Too Isolated
Industry Worries New Medicare Board Will Be Too Isolated
Senators Plan Effort To Repeal Independent Payment Advisory Board
DME Competitive Bidding: 32% Cost-Cutting Expected From Revived Program

Topics

Advertisement
UsernamePublicRestriction

Register

MT030349

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel